Trademarkia Logo

Canada

C$
Trademark Search in Canada
ROYAL HIGH

View On IC.GC.CA

ROYAL HIGH
REGISTERED

on 2 Aug 2023

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

UNITED GREENERIES LTD.

5250 Mission RoadDuncan

BRITISH COLUMBIA

CA

V9L6V2

Serial Number

1867271 filed on 9th Nov 2017

Registration Number

TMA1193045 registered on 2th Aug 2023

Registration expiry Date

2th Aug 2033

Correspondent Address

LISA D. STATT FOY

(Field LLP)400 - 444 7 Avenue SWCALGARY

ALBERTA

CA

T2P0X8

ROYAL HIGH

Trademark usage description

cannabinoids and cannabis compounds namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivaran, and ca Read More

Classification Information

Class [001]
Cannabinoids and cannabis compounds namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivaran, and cannabichromene, for use in pharmaceuticals

Classification kind code

11

Class [003]
Cosmetics with cannabinoid content; cannabis preparations in the form of personal care preparations for the body, namely body care cosmetics namely, creams, oils, emollients, ointments, rubs, lotions, and salves; cannabinoids and cannabis compounds, namely, Cannabigerols, Cannabichromenes, Cannabidiol, Tetrahydrocannabinol, Cannabinol, Cannabinodiol, cannabicyclol, cannabielsoin, and cannabitriol for cosmetic purposes

Classification kind code

11

Class [005]
Pharmaceuticals for the relief of pain and treatment of nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders namely tremors, Parkinson's disease, Huntington's disease, Tourette syndrome, dyskinesia, dystonia, ataxia and restless leg syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals containing cannabinoids as the active ingredient, medicines containing a tetrahydrocannabinol extract; medicines derived from cannabis namely medicinal cannabis for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders namely tremors, Parkinson's disease, Huntington's disease, Tourette syndrome, dyskinesia, dystonia, ataxia and restless leg syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceutical preparations for the relief of pain nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; cannabis products, namely medicines, namely medicinal dried cannabis, and medicines containing a tetrahydrocannabinol extract, namely tetrahydrocannabinol [THC] oil for medical purposes, for clinical studies; cannabinoids and cannabis compounds namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene, for use in pharmaceuticals; cannabis compounds, namely medicines containing a tetrahydrocannabinol extract namely tetrahydrocannabinol for medical purposes; cannabis based pharmaceuticals for the relief of pain and treatment of nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders namely tremors, Parkinson's disease, Huntington's disease, Tourette syndrome, dyskinesia, dystonia, ataxia and restless leg syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis and; nutraceuticals, namely antioxidant pills, dietary supplements for general health and well-being, adult vitamins, minerals, and herbal supplements for general health and well-being; synthetic narcotics for medical use; nutritional and dietary supplements for general health and well-being; products, plants, dried plant material, seeds and medicines derived from the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; dried cannabis, namely, medical marihuana; dried medical marihuana; dried cannabis namely dried medical marihuana; cannabis products namely dried cannabis and dried hashish for medical use. Pharmaceuticals namely anti-epileptic pharmaceutical preparations, pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis and pharmaceutical preparations for the prevention and treatment of cancer; nutraceuticals namely anti-epileptic nutraceutical preparations for the treatment of degenerative nerve diseases and disorders, namely Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis and nutraceutical preparations for the prevention and treatment of cancer; cannabinoids and cannabis compounds namely Cannabigerol, Cannabichromenes, Cannabidiol, Tetrahydrocannabinol, Cannabinol, Cannabinodiol, cannabicyclol, cannabielsoin, and cannabitriol for medical purposes;

Classification kind code

11

Class [029]
Consumer products containing cannabis namely, cannabis oil for food and edible cannabis oil for food

Classification kind code

11

Class [030]
Consumer products containing cannabis namely, brownies and chocolate bars infused with cannabis

Classification kind code

11

Class [034]
Cannabis oil for oral vaporizers for smoking; cannabis products, namely dried cannabis; cannabinoids and cannabis compounds namely Cannabigerol, Cannabichromenes, Cannabidiol, Tetrahydrocannabinol, Cannabinol, Cannabinodiol, cannabicyclol, cannabielsoin, and cannabitriol for smoking purposes

Classification kind code

11

Class [035]
Retail and wholesale store reward program; mail order medical marihuana clubs; membership services, namely the operation and maintenance of a membership organization for retail and wholesale stores in the field of medical marihuana, namely for promoting the interest of medical marihuana stores; retail and wholesale sales of medical marihuana and seeds; providing medical marihuana, namely providing the retailing, wholesaling of medical marihuana; sale of medical marihuana and cannabis extracts; sale of medical marihuana and cannabis extracts, namely hashish and cannabis resins; retail and wholesale sales of cannabis; Sale of consumer products containing cannabis, cannabinoids and cannabis compounds namely, cannabis oil for food, edible cannabis oil for food, and brownies and chocolate bars infused with cannabis

Classification kind code

11

Class [039]
Distributing, namely truck transport of pharmaceuticals containing cannabinoids and cannabis compounds; distributing, namely truck transport of pharmaceuticals, pharmaceutical products, and nutraceuticals; providing medical marihuana, namely providing the distribution of medical marihuana, namely by transport by truck, air, boat and rail;

Classification kind code

11

Class [040]
Assembly of pharmaceuticals for others; Developing and producing, namely custom manufacturing of pharmaceuticals containing cannabinoids and cannabis compounds; developing, producing, namely manufacturing to the order and specification of others of pharmaceuticals, pharmaceutical products, and nutraceuticals

Classification kind code

11

Class [042]
Developing and producing pharmaceuticals namely development of pharmaceutical preparations and medicines; product development services; development of cannabis products, namely cannabis, medicines, and medicines containing a tetrahydrocannabinol extract, for clinical studies

Classification kind code

11

Class [044]
Breeding, growing and processing namely cultivation, harvesting and production, of cannabis; dispensing medicinal marijuana and cannabis based products, namely cannabis based pharmaceuticals and nutraceuticals; Operation of a dispensary for dried cannabis and pharmaceuticals, and nutraceuticals; online operation of a dispensary for dried cannabis for dried cannabis and pharmaceuticals, and nutraceuticals; distributing pharmaceuticals, namely dispensing of pharmaceutical preparations and medicines; providing information via a computer database in the field of medical marihuana; providing information via a website in the field of medical marihuana; dispensing pharmaceuticals; dispensing pharmaceuticals containing cannabinoids and cannabis compounds; dispensing cannabis products, namely hashish, cannabis, cannabis seeds, pharmaceuticals and nutraceuticals containing cannabis, cannabinoids or cannabis compounds; dispensing pharmaceutical products containing cannabis; dispensing cannabis; dispensing marihuana; providing information via a website in the field of medical marihuana and medical cannabis

Classification kind code

11

Mark Details

Serial Number

1867271

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 26th Nov 2020		Agent Changed
Submitted for opposition 135
on 11th Jun 2020		Amendment to Application
Submitted for opposition 15
on 14th Apr 2020		Correspondence Created
Submitted for opposition 135
on 30th Jan 2020		Amendment to Application
Submitted for opposition 12
on 12th Jul 2019		Extension of Time
Submitted for opposition 22
on 21st Dec 2018		Search Recorded
Submitted for opposition 20
on 21st Dec 2018		Examiner's First Report
Submitted for opposition 31
on 14th Nov 2017		Formalized
Submitted for opposition 1
on 10th Nov 2017		Created
Submitted for opposition 30
on 9th Nov 2017		Filed